177 related articles for article (PubMed ID: 18606364)
1. How to predict and prevent the immunogenicity of therapeutic proteins.
Schellekens H
Biotechnol Annu Rev; 2008; 14():191-202. PubMed ID: 18606364
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the immunogenicity of therapeutic proteins.
Schellekens H
Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi3-9. PubMed ID: 15958824
[TBL] [Abstract][Full Text] [Related]
3. Hypotheses on a germline origin of antibody diversity. Possible applications: improvement of the efficiency of immune response and autoimmune disease treatment.
Berger G
Med Hypotheses; 2004; 63(5):847-54. PubMed ID: 15488659
[TBL] [Abstract][Full Text] [Related]
4. B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins?
Sauerborn M; Schellekens H
Curr Opin Biotechnol; 2009 Dec; 20(6):715-21. PubMed ID: 19892544
[TBL] [Abstract][Full Text] [Related]
5. Animal models as indicators of immunogenicity of therapeutic proteins in humans.
Bussiere JL
Dev Biol (Basel); 2003; 112():135-9. PubMed ID: 12762512
[TBL] [Abstract][Full Text] [Related]
6. Identification and removal of immunogenicity in therapeutic proteins.
Baker MP; Jones TD
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):219-27. PubMed ID: 17436557
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of therapeutic cytokines.
Herzyk DJ
Curr Opin Mol Ther; 2003 Apr; 5(2):167-71. PubMed ID: 12772507
[TBL] [Abstract][Full Text] [Related]
8. The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.
Patten PA; Schellekens H
Dev Biol (Basel); 2003; 112():81-97. PubMed ID: 12762507
[TBL] [Abstract][Full Text] [Related]
9. Intensive therapy for diabetes through influence on innate immune system.
Li ZZ; Liu JB; Li L; Jiao L; Chen L
Med Hypotheses; 2009 Jun; 72(6):675-6. PubMed ID: 19264419
[TBL] [Abstract][Full Text] [Related]
10. How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerations.
Jahn EM; Schneider CK
N Biotechnol; 2009 Jun; 25(5):280-6. PubMed ID: 19491045
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of protein therapeutics.
De Groot AS; Scott DW
Trends Immunol; 2007 Nov; 28(11):482-90. PubMed ID: 17964218
[TBL] [Abstract][Full Text] [Related]
12. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs.
Shankar G; Pendley C; Stein KE
Nat Biotechnol; 2007 May; 25(5):555-61. PubMed ID: 17483842
[TBL] [Abstract][Full Text] [Related]
13. The implications of immunogenicity for protein-based multiple sclerosis therapies.
Cohen BA; Oger J; Gagnon A; Giovannoni G
J Neurol Sci; 2008 Dec; 275(1-2):7-17. PubMed ID: 18822434
[TBL] [Abstract][Full Text] [Related]
14. Factors that contribute to the immmunogenicity of therapeutic recombinant human proteins.
Mukovozov I; Sabljic T; Hortelano G; Ofosu FA
Thromb Haemost; 2008 May; 99(5):874-82. PubMed ID: 18449416
[TBL] [Abstract][Full Text] [Related]
15. Minimizing the immunogenicity of protein therapeutics.
Chirino AJ; Ary ML; Marshall SA
Drug Discov Today; 2004 Jan; 9(2):82-90. PubMed ID: 15012932
[TBL] [Abstract][Full Text] [Related]
16. Reflections on the immunogenicity of therapeutic proteins.
Antonelli G
Clin Microbiol Infect; 2008 Aug; 14(8):731-3. PubMed ID: 18325035
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity assessment of therapeutic proteins and peptides.
Kaliyaperumal A; Jing S
Curr Pharm Biotechnol; 2009 Jun; 10(4):352-8. PubMed ID: 19519410
[TBL] [Abstract][Full Text] [Related]
18. Assessing immunogenicity in the presence of excess protein therapeutic using immunoprecipitation and quantitative mass spectrometry.
Neubert H; Grace C; Rumpel K; James I
Anal Chem; 2008 Sep; 80(18):6907-14. PubMed ID: 18702532
[TBL] [Abstract][Full Text] [Related]
19. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.
Schwartz M; London A; Shechter R
Neuroscience; 2009 Feb; 158(3):1133-42. PubMed ID: 19103265
[TBL] [Abstract][Full Text] [Related]
20. Can we prevent immunogenicity of human protein drugs?
Scott DW; De Groot AS
Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i72-76. PubMed ID: 19995750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
